Growth factors, cytokines, and renal fibrosis during the course of diabetic nephropathy

Diabetes and Metabolism

Volumn 26, Issue SUPPL. 4, 2000, Pages 16-24

  Rossert, J ^a,b   Terraz Durasnel, C ^b   Brideau, G ^b  

^a HÔPITAL TENON   (France)

^b INSERM   (France)

Author keywords

Diabetic nephropathy; Fibrosis; TGF

Indexed keywords

ANGIOTENSIN; CYTOKINE; ENDOTHELIN 1; GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 4; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN BINDING PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA;

CELL FUNCTION; CONFERENCE PAPER; DIABETIC NEPHROPATHY; DISEASE COURSE; EXTRACELLULAR MATRIX; GLOMERULUS BASEMENT MEMBRANE; GLYCOSYLATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FIBROSIS; LIPID PEROXIDATION; MESANGIUM; PROTEINURIA;

ANIMALS; CYTOKINES; DIABETIC NEPHROPATHIES; FIBROSIS; GROWTH SUBSTANCES; HUMANS; KIDNEY;

EID: 0033855202     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. Ziyadeh FN. The extracellular matrix in diabetic nephropathy. Am J Kidney Dis, 1993, 22, 736-744.
2. Rossert J, Garrett LA. Regulation of type I collagen synthesis. Kidney Int, 1995, 47 (suppl. 49), S34-S38.
3. Massagué J. The transforming growth factor-β family. Annu Rev Cell Dev Biol, 1990, 6, 597-641.
4. Crawford SE, Stellmach V, Murphy-Ullrich JE et al. Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell, 1998, 93, 1159-1170.
5. Massagué J. TGFβ signaling: receptors, transducers, and Mad proteins. Cell, 1996, 85, 947-950.
6. Derynck R, Zhang Y, Feng XH. Smads: transcriptional activators of TGF-beta responses. Cell, 1998, 95, 737-740.
7. Ulloa L, Doody J, Massagué J. Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway. Nature, 1999, 397, 710-713.
8. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. J Clin Invest, 1993, 92, 2597-2601.
9. Sanderson N, Factor V, Nagy P et al. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci (U S A), 1995, 92, 2572-2576.
10. Kopp JB, Factor VM, Mozes M et al. Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Invest, 1996, 74, 991-1003.